Jubilant Life appoints Novartis Syed Kazmi as President, CEO of its new biotech startup Medical Dialogues Bureau11 Sept 2019 9:25 AM ISTDr Syed Kazmi joins from Novartis Pharmaceuticals Corporation where he was Vice President, Global Head of Business Development & Licensing for...
USFDA puts partial hold on Abbvie Venclexta clinical trials after deaths Farhat Nasim21 March 2019 9:45 AM ISTThe clinical hold does not impact any of the approved indications for Venclexta, such as chronic lymphocytic leukaemia (CLL) or acute myeloid...
Novartis Rydapt wins EU approval for AML, other diseases Ruby Khatun Khatun22 Sept 2017 9:57 AM ISTZURICH: Swiss drugmaker Novartis on Wednesday won European Union approval for Rydapt to be used against a mutated form of acute myeloid leukemia (AML)...